Structure of cholecystokinin receptor binding sites and mechanism of activation/inactivation by agonists/antagonists

被引:38
|
作者
Fourmy, D
Escrieut, C
Archer, E
Galès, C
Gigoux, V
Maigret, B
Moroder, L
Silvente-Poirot, S
Martinez, J
Fehrentz, JA
Pradayrol, L
机构
[1] CHU Rangueil, INSERM, U531, Louis Buhnard Inst, F-31403 Toulouse 4, France
[2] Univ Nancy, UHP, CNRS, UMR 7565, F-54506 Vandoeuvre Les Nancy, France
[3] Max Planck Inst Biochem, D-82143 Martinsried, Germany
[4] Fac Pharm Montpellier, CNRS, UMR 5810, F-34060 Montpellier, France
来源
PHARMACOLOGY & TOXICOLOGY | 2002年 / 91卷 / 06期
关键词
D O I
10.1034/j.1600-0773.2002.910608.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Delineation of CCK receptor binding sites is a prerequisite for the understanding of the molecular basis for ligand recognition, partial agonism. ligand-induced traffiking of receptor signalling. In the current paper, we illustrate how, in the past 5 years, studies from our laboratory and others have provided new data on the molecular basis of the pharmacology and functioning of CCK1 and CCK2 receptors. Available data on CCK1 and CCK2R binding sites indicate that 1) homologous regions of the two receptors are involved in the binding site of CCK, however, positioning of CCK slightly differs; 2) binding sites of non-peptide agonists/antagonist are buried in the pocket formed by transmembrane helices and overlap that of CCK and 3) residues of the binding sites as well as of conserved motifs such as E/DRY, NPXXY are crucial for receptor activation.
引用
收藏
页码:313 / 320
页数:8
相关论文
共 50 条
  • [11] DIFFERENTIAL BINDING OF AGONISTS AND ANTAGONISTS TO GABA RECEPTOR POPULATIONS
    MAKSAY, G
    TICKU, MK
    [J]. FEDERATION PROCEEDINGS, 1984, 43 (03) : 286 - 286
  • [12] Immunologic evidence for cholecystokinin receptor internalization and recycling: Effects of agonists and antagonists.
    Toledo, C
    MorysWortmann, C
    Schmidt, WE
    Roettger, BF
    Miller, LJ
    [J]. GASTROENTEROLOGY, 1996, 110 (04) : A438 - A438
  • [13] Structure-based understanding of binding affinity and mode of estrogen receptor a agonists and antagonists
    Lee, Sehan
    Barron, Mace
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2017, 253
  • [14] Structure-Based Understanding of Binding Affinity and Mode of Estrogen Receptor α Agonists and Antagonists
    Lee, Sehan
    Barron, Mace G.
    [J]. PLOS ONE, 2017, 12 (01):
  • [15] Analysis of GABAA Receptor Activation by Combinations of Agonists Acting at the Same or Distinct Binding Sites
    Shin, Daniel J.
    Germann, Allison L.
    Covey, Douglas F.
    Steinbach, Joe Henry
    Akk, Gustav
    [J]. MOLECULAR PHARMACOLOGY, 2019, 95 (01) : 70 - 81
  • [16] CONFORMATIONAL SHIFTS AT THE BENZODIAZEPINE RECEPTOR RELATED TO THE BINDING OF AGONISTS ANTAGONISTS AND INVERSE AGONISTS
    FRYER, RI
    COOK, C
    GILMAN, NW
    WALSER, A
    [J]. LIFE SCIENCES, 1986, 39 (21) : 1947 - 1957
  • [17] The AMPA receptor binding site: Focus on agonists and competitive antagonists
    Stensbol, TB
    Madsen, U
    Krogsgaard-Larsen, P
    [J]. CURRENT PHARMACEUTICAL DESIGN, 2002, 8 (10) : 857 - 872
  • [18] Cannabinoid agonists and antagonists discriminated by receptor binding in rat cerebellum
    Griffin, G
    Wray, EJ
    Martin, BR
    Abood, ME
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1999, 128 (03) : 684 - 688
  • [19] INTERACTIONS OF ESTROGEN AGONISTS AND ANTAGONISTS WITH CATECHOLAMINE RECEPTOR-BINDING
    HIEMKE, C
    BANGER, M
    GHRAF, R
    [J]. HOPPE-SEYLERS ZEITSCHRIFT FUR PHYSIOLOGISCHE CHEMIE, 1983, 364 (09): : 1144 - 1144
  • [20] QUANTITATIVE ASPECTS OF THE RECEPTOR-BINDING OF CYTOKININ AGONISTS AND ANTAGONISTS
    IWAMURA, H
    MASUDA, N
    KOSHIMIZU, K
    MATSUBARA, S
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1983, 26 (06) : 838 - 844